DuPont agrees to $875 million New Jersey settlement, pending court approval
On August 3, 2025, DuPont, Chemours and Corteva agreed to a proposed judicial consent order with the State of New Jersey to resolve state claims over legacy contamination, including PFAS, subject to court approval. DuPont recorded a $177 million pre-tax charge in discontinued operations in the second quarter of 2025, reflecting the net present value of $311 million, which the filing estimates as its share of the settlement payments, so the settlement adds a large cost for shareholders.
Key points
- Aggregate cash payment to New Jersey of $875 million, payable over 25 years and shared under the 2021 MOU among DuPont, Chemours and Corteva.
- Second-quarter 2025 pre-tax charge of $177 million within discontinued operations; DuPont's estimated share of payments has a net present value of $311 million at an 8 percent discount rate.
- DuPont and Corteva will establish a $475 million Reserve Fund, and DuPont will contribute $106.5 million of a $150 million NJ Escrow tied to Chemours' share of the settlement.
- First annual payment due within 30 days of court entry, and no earlier than January 31, 2026; the settlement is subject to a public comment period and the company admits no liability.
The filing
Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.